Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system (CNS) drugs and anti-inflammatory agents. Its structure, featuring amino, bromo, carboxylic acid, and trifluoromethoxy groups, allows for selective functionalization, making it valuable in constructing complex heterocyclic compounds. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the presence of multiple reactive sites. Also utilized in the preparation of kinase inhibitors and other biologically active molecules where the trifluoromethoxy and bromo groups serve as handles for cross-coupling reactions.